Acro Biomedical ACBM Income Statement (2015-2026)

OTC ACBM
$0.03 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Acro Biomedical Quarterly Income Statement

Periods 43 quarters
Latest Jun 2026

Acro Biomedical reported net income of -$0.02M for the quarter ended Jun 2026. This income statement covers 43 quarters of results from Sep 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue
0.50M0.60M0.30M0.36M
Cost of RevenueCost of Rev
0.42M0.45M0.22M0.30M
Gross Profit
0.08M0.15M0.08M0.06M
Operating items
Research & DevelopmentR&D
0.64M2.12M2.52M2.52M2.52M2.52M2.52M2.52M1.88M0.40M
Selling, General & AdministrativeSG&A
0.23M0.87M1.48M1.49M1.48M1.49M1.48M1.48M1.32M0.70M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.12M0.02M0.02M
Other Operating ExpensesOther Opex
0.49M
Operating ExpensesOpex
0.87M2.99M4.00M4.01M4.00M4.01M4.00M4.00M3.19M1.59M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.12M0.02M0.02M
Operating IncomeOp. Inc
-0.79M-2.99M-3.85M-3.93M-4.00M-4.01M-3.93M-4.00M-3.19M-1.59M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.12M-0.02M-0.02M
EBIT
-0.79M-2.99M-3.85M-3.93M-4.00M-4.01M-3.93M-4.00M-3.19M-1.59M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.12M-0.02M-0.02M
Non-operating items
Non Operating Interest Expenses
0.00M178.00202.00209.00211.00499.00787.00788.00789.00790.00839.00954.000.00M0.00M0.00M0.00M0.00M0.00M
Other Non Operating IncomeOther Non Op Inc.
-0.00M-0.00M
Non Operating IncomeNon Op. Inc.
0.00M
Net income details
EBT
-0.79M-2.99M-3.85M-3.93M-4.00M-4.01M-3.93M-4.00M-3.20M-1.59M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.12M0.04M-0.02M
Tax ProvisionsTaxes
-1.62M-1.85M-0.01M-0.02M
Profit After TaxPAT
-0.79M-2.99M-3.85M-3.93M-4.00M-4.01M-3.93M-4.00M-3.20M-1.59M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.12M0.04M-0.02M
Income from Non-Controlling InterestsInc. Minority
0.48M
Income from Continuing OperationsIncome (Continuing)
-0.79M-2.99M-2.24M-3.93M-4.00M-4.01M-3.93M-4.00M-3.20M-1.59M1.83M-0.01M-0.01M-0.01M-0.00M-0.01M-0.02M-0.12M0.06M-0.02M
Consolidated Net IncomeConsol Net Inc.
-0.79M-2.99M-2.24M-3.93M-4.00M-4.01M-3.93M-4.00M-3.20M-1.59M1.83M-0.01M-0.01M-0.01M-0.00M-0.01M-0.02M-0.12M0.06M-0.02M
Income towards Parent CompanyParent Net Inc
-0.79M-2.99M-2.24M-3.93M-4.00M-4.01M-3.93M-4.00M-3.20M-1.59M1.83M-0.01M-0.01M-0.01M-0.00M-0.01M-0.02M-0.12M0.06M-0.02M
Net Income towards Common StockholdersNet Income
-0.79M-2.99M-2.24M-3.93M-4.00M-4.01M-3.93M-4.00M-3.20M-1.59M1.83M-0.01M-0.01M-0.01M-0.00M-0.01M-0.02M-0.12M0.06M-0.02M
Additional items
EPS (Basic)
-0.02-0.05-0.04-0.07-0.07-0.07-0.07-0.07-0.05-0.030.030.000.000.000.000.000.000.000.000.00
EPS (Diluted)
-0.02-0.06-0.04-0.07-0.07-0.07-0.07-0.07-0.05-0.030.030.000.000.000.000.000.000.000.000.00
Shares Outstanding
50.52M56.87M56.87M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
47.76M47.76M53.84M53.84M53.84M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
54.54M60.04M60.04M60.04M60.04M60.04M60.04M
EBITDA
-0.79M-2.99M-3.85M-3.93M-4.00M-4.01M-3.93M-4.00M-3.19M-1.59M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.12M-0.02M-0.02M
Interest ExpensesInt Expense
0.00M178.00202.00209.00211.00499.00787.00788.00789.00790.00839.00954.000.00M0.00M0.00M0.00M0.00M0.00M
Tax Rate
41.96%10,140.30%83.22%-49.95%